Your cervical cancer prognosis depends on various things. You may be feeling pretty powerless right now and concerned for your future. You can get yourself informed and take control of your treatment and your prognosis.

Chemotherapy, surgery, hormone therapy and radiotherapy are not the only available treatments for ovarian cancer. Your oncologist will likely not know much about them for a few reasons.

These days, all mainstream cancer treatment is directed by drug company money and investment. It is well documented that competition is contained by various organizations with financial and professional interests in the cancer industry. You are free to research this further.

The average cancer patient generates tens of thousands of dollars for cancer drug and treatment providers before they die.

Few oncologists tell their patients that there are dozens of inexpensive and effective substances around that offset the side effects of chemotherapy and radiation. Why? Medical training focuses on surgery and FDA-approved drugs, so many doctors simply aren't exposed to the alternatives. Despite this, a survey of 64 staff oncologists at Canada's McGill Cancer Therapy Center found that 91% would not take chemotherapy themselves nor allow their family members to take it for cancer treatment because of its high toxicity and low effectiveness. Ironically, 75% of cancer patients are given chemotherapy as standard cancer treatment.

Pap smears are the only established method for cervical cancer screening. This test involves brushing cells off the surface of the cervix and examining the cells under a microscope for the presence of cancerous or precancerous changes or lesions. Presently, Pap smear is a routine test for women in most developed countries and this has really helped to reduce the number of deaths that are recorded due to cervical cancer. However, some critics have argued that the Pap smear test is not always completely accurate. It is advisable to carry out the test in at least two laboratories, seek at least two professional opinions and then compare, especially if you observe early symptoms of cervical cancer or you believe you are perfectly alright but the test result shows otherwise.

Treatment for ovarian cysts of these types generally involves surgery. The severity of the condition is basically the basis for choosing the type of surgery to be employed. Ovarian cystectomy is focused on the removal of the cyst itself, while partial oophorectomy refers to the elimination of the part of the ovary where the cysts have taken root. The most drastic of measures involves those of salpingo-oophorectomy which takes away the ovary and the fallopian tube and total abdominal hysterectomy with bilateral salpingo-oophorectomy that removes the cysts, ovary, fallopian tube and the uterus to totally rid the body of further harm from this type of cysts

Signature***********************
Mortgage refinancing Mortgage Calculator
mortgage refinance through our articles
most exquisite condominiums residences

Tags: pap smear, Cancer, mortgage refinancing, condominiums, cancer ovarian cervical, cervical cancer prognosis, mainstream cancer, mortgage refinance

Each HIV-infected patient initially entering into care should have a complete medical history, physical examination, laboratory evaluation, and counseling. The purpose is to confirm the presence of HIV infection, obtain appropriate baseline historical and laboratory data, assure patient understanding about HIV infection, and initiate care as recommended by the HIV primary care guidelines and by the opportunistic treatment and prevention guidelines. Baseline data then is utilized to define management goals and future plans.

The following laboratory tests should be performed for a new patient during initial patient visits:

•  HIV antibody testing (if prior documentation not available) or if HIV RNA is undetectable (AI);
- CD4 + cell count
•  Plasma HIV RNA (viral load) (AI);
•  Complete blood count, chemistry profile, transaminase levels, BUN and creatinine, urinalysis, screening test
for syphilis (e.g., RPR, VDRL, or treponema EIA), tuberculin skin test (TST) or interferon-? release assay
IGRA (unless there is history of a prior TB or positive TST or IGRA), anti Toxoplasma gondii IgG,
hepatitis A, B, and C serologies, and Pap smear in women;
- Fasting blood glucose and serum lipids if the person is considered to be at risk for heart disease and for
baseline evaluation before the start of ARV therapy and
• For patients who have pretreatment HIV RNA >1,000 copies/mL, genotypic resistance testing when the
patient enters into care, regardless of whether therapy will be initiated immediately (AIII). For patients who
have HIV RNA levels of 500–1,000 copies/mL, resistance testing also may be considered, even though
amplification may not always be successful (BII). If therapy is deferred, repeat testing at the time of
antiretroviral initiation should be considered (CIII).

Patients living with HIV infection must often cope with multiple social, psychiatric, and medical issues that are best
addressed through a multidisciplinary approach to the disease. The evaluation also must include assessment of
drug abuse, economic factors (e.g., unstable housing), social support, mental illness, comorbidities, high-risk behaviors, and other factors that are known to impair the ability to adhere to treatment and to promote education about HIV Once evaluated, these factors should be managed accordingly.
Lastly,  risk behaviors and effective strategies to prevent HIV transmission. to others should be
provided at each patient clinic visit.

Tags: AIDS, HIV, laboratory evaluation, Health, pap smear, HIV Treatment, hiv rna levels, blood glucose